Delivery Order 36F79720D0099-36C24621N0912
Award Date 6/23/21
Potential Completion Date 7/1/21
Potential Value $10K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Otsuka America Pharmaceutical Inc. was awarded a $12,195.72 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the drug JYNARQUE 90MG/30MG and has a period of performance through May 5, 2023. To be delivered to the place of performance in Pittsburgh, Pennsylvania, the product will support VHA's healthcare services for veterans...
- Otsuka America Pharmaceutical Inc. was awarded a $12,559.90 firm fixed-price delivery order by Veterans Integrated Service Network 5 (VISN 5) on September 24, 2024, for the supply of Jynarque 90mg/30mg, a specialty pharmaceutical treatment for autosomal dominant polycystic kidney disease and hyponatremia. The delivery order, with an ultimate completion date of September 30, 2024, will be performed at a location in Belle Isle, Florida. This award does not utilize a set-aside designation,...
- On May 25, 2021, the Department of Veterans Affairs' Veterans Integrated Service Network 5 (VISN 5) awarded a delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 60 mg, a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. The contract, valued at $10,298.57, was issued on a firm fixed-price basis with no set-aside designation and was completed by May 28, 2021. This delivery order was issued under Otsuka America Pharmaceutical Inc.'s...
- Otsuka America Pharmaceutical Inc. was awarded a delivery order by Veterans Integrated Service Network 5 (VISN 5) for Jynarque 90mg/30mg on November 12, 2021, with a ceiling value of $10,375.04. The contract is firm fixed price with no set-aside designation and was completed by November 17, 2021. This delivery order was issued under the company's broader Blanket Purchase Agreement for Jynarque valued at $83.3 million with the VA's National Acquisition Center, which operates under the...
- Otsuka America Pharmaceutical Inc. was awarded a delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The $0 firm fixed price order is for the drug JYNARQUE 45MG-15MG and has a period of performance through October 2023. To be delivered to the Pittsburgh, PA area, this represents a contract for pharmaceutical products to support treatment services for veterans...
- Otsuka America Pharmaceutical Inc. was awarded a $12.6K firm fixed price delivery order by Veterans Integrated Service Network 21 on September 20, 2024, for Jynarque (tolvaptan) in tablet form—specifically 15mg and 45mg dosages in a 14-day dose pack configuration. The contract, which is not subject to any set-aside designation, is scheduled for ultimate completion on October 20, 2024, with performance taking place in Potomac, Maryland. This delivery order falls under the Pharmaceuticals and...
- On April 10, 2024, the Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 90mg-30mg with a ceiling value of $12,559.90. This firm fixed-price delivery order, with an ultimate completion date of April 15, 2024, will be performed in Pittsburgh, Pennsylvania. The award was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize any set-aside...
- Otsuka America Pharmaceutical Inc. was awarded a delivery order by Veterans Integrated Service Network 5 (VISN 5) on June 21, 2024, for the supply of Jynarque (tolvaptan) in 90mg-30mg formulation. This firm fixed-price delivery order has a ceiling value of $12,559.90 and an ultimate completion date of June 24, 2024, with performance to be completed in Pittsburgh, Pennsylvania. The contract does not utilize any set-aside designations. This delivery order is issued under Otsuka America...
- On June 4, 2024, the Department of Veterans Affairs, specifically Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $12,559.90 to Otsuka America Pharmaceutical Inc. for the supply of Jynarque 90mg/30mg. This firm-fixed price delivery order, with an ultimate completion date of June 7, 2024, represents a procurement of specialty pharmaceutical products under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract contains no set-aside...
- Otsuka America Pharmaceutical Inc. received a delivery order award from the Department of Veterans Affairs' Veterans Integrated Service Network 20 on August 5, 2021, for the supply of Jynarque (tolvaptan) in tablet form—specifically 15mg and 45mg dosages in a 14-day dose pack. The contract, valued at $10,303.55, operates under a firm fixed price arrangement with no set-aside designation and is set for completion by November 2, 2021. The place of performance is Potomac, Maryland. This delivery...